|

Group A Standard-of-Care Backbone Therapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Children's National Research Institute1

Indications

  • Embryonal Brain Tumor Not Otherwise Specified1
  • Embryonal Tumor of CNS1
  • Atypical Teratoid/Rhabdoid Tumor of CNS1
  • Embryonal Tumor With Multilayered Rosettes1
  • Pineoblastoma1

Washington D.C., District of Columbia1 trial

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Children's National Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.